HEADER TRANSFERASE/INHIBITOR 09-AUG-18 6EDL TITLE HALK IN COMPLEX WITH COMPOUND 1 (S)-N-(1-(2,4-DIFLUOROPHENYL)ETHYL)-3- TITLE 2 (3-METHYL-1H-PYRAZOL-5-YL)IMIDAZO[1,2-B]PYRIDAZIN-6-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS INHIBITOR, COMPLEX, KINASE, SBDD, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.LANE,K.SAIKATENDU REVDAT 5 13-MAR-24 6EDL 1 REMARK REVDAT 4 05-JUN-19 6EDL 1 JRNL REVDAT 3 15-MAY-19 6EDL 1 JRNL REVDAT 2 08-MAY-19 6EDL 1 JRNL REVDAT 1 01-MAY-19 6EDL 0 JRNL AUTH M.FUSHIMI,I.FUJIMORI,T.WAKABAYASHI,T.HASUI,Y.KAWAKITA, JRNL AUTH 2 K.IMAMURA,T.KATO,M.MURAKAMI,T.ISHII,Y.KIKKO,M.KASAHARA, JRNL AUTH 3 A.NAKATANI,Y.HIURA,M.MIYAMOTO,K.SAIKATENDU,H.ZOU,S.W.LANE, JRNL AUTH 4 J.D.LAWSON,H.IMOTO JRNL TITL DISCOVERY OF POTENT, SELECTIVE, AND BRAIN-PENETRANT 1 JRNL TITL 2 H-PYRAZOL-5-YL-1 H-PYRROLO[2,3- B]PYRIDINES AS ANAPLASTIC JRNL TITL 3 LYMPHOMA KINASE (ALK) INHIBITORS. JRNL REF J.MED.CHEM. V. 62 4915 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31009559 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01630 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 7933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 635 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.4233 - 4.7838 1.00 1549 134 0.2196 0.2784 REMARK 3 2 4.7838 - 3.7981 1.00 1480 129 0.2011 0.2774 REMARK 3 3 3.7981 - 3.3183 1.00 1455 127 0.2203 0.2596 REMARK 3 4 3.3183 - 3.0150 1.00 1432 125 0.2707 0.2947 REMARK 3 5 3.0150 - 2.7990 0.96 1382 120 0.2969 0.3497 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2269 REMARK 3 ANGLE : 1.298 3092 REMARK 3 CHIRALITY : 0.073 347 REMARK 3 PLANARITY : 0.006 400 REMARK 3 DIHEDRAL : 4.100 1891 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 13.8264 -9.8619 -16.9649 REMARK 3 T TENSOR REMARK 3 T11: 0.2426 T22: 0.2650 REMARK 3 T33: 0.2896 T12: -0.0274 REMARK 3 T13: -0.0129 T23: -0.0697 REMARK 3 L TENSOR REMARK 3 L11: 1.7843 L22: 2.2303 REMARK 3 L33: 2.0346 L12: -0.6040 REMARK 3 L13: 0.1111 L23: -0.4706 REMARK 3 S TENSOR REMARK 3 S11: -0.0022 S12: 0.0119 S13: -0.0610 REMARK 3 S21: -0.0096 S22: 0.1211 S23: -0.1178 REMARK 3 S31: 0.1290 S32: -0.0643 S33: 0.0002 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EDL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1000235612. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7935 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 38.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.16200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.87200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM TRIS PH 8.0, 150 MM NACL, 0.5 MM REMARK 280 EDTA, 1 MM BENZAMIDINE AND 0.25 MM TCEP, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.78550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.70500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.70450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.70500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.78550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.70450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1085 REMARK 465 ALA A 1086 REMARK 465 MET A 1087 REMARK 465 GLY A 1088 REMARK 465 SER A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 GLY A 1125 REMARK 465 ALA A 1126 REMARK 465 PHE A 1127 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 GLY A 1272 REMARK 465 MET A 1273 REMARK 465 ALA A 1274 REMARK 465 ARG A 1275 REMARK 465 ASP A 1276 REMARK 465 ILE A 1277 REMARK 465 TYR A 1278 REMARK 465 ARG A 1279 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 GLY A 1287 REMARK 465 GLU A 1400 REMARK 465 TYR A 1401 REMARK 465 GLY A 1402 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A1124 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A1129 CG CD OE1 OE2 REMARK 470 ARG A1209 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1214 CG CD NE CZ NH1 NH2 REMARK 470 GLN A1217 CG CD OE1 NE2 REMARK 470 MET A1290 CG SD CE REMARK 470 GLU A1299 CG CD OE1 OE2 REMARK 470 GLN A1364 CG CD OE1 NE2 REMARK 470 ARG A1382 CG CD NE CZ NH1 NH2 REMARK 470 TYR A1385 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A1119 -111.46 -143.56 REMARK 500 SER A1219 64.91 -116.51 REMARK 500 LEU A1221 139.76 -172.84 REMARK 500 ARG A1248 -3.33 75.30 REMARK 500 ASP A1249 46.98 -152.27 REMARK 500 SER A1344 1.10 -67.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1614 DISTANCE = 6.60 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J4M A 1500 DBREF 6EDL A 1090 1406 UNP Q9UM73 ALK_HUMAN 1090 1406 SEQADV 6EDL GLY A 1085 UNP Q9UM73 EXPRESSION TAG SEQADV 6EDL ALA A 1086 UNP Q9UM73 EXPRESSION TAG SEQADV 6EDL MET A 1087 UNP Q9UM73 EXPRESSION TAG SEQADV 6EDL GLY A 1088 UNP Q9UM73 EXPRESSION TAG SEQADV 6EDL SER A 1089 UNP Q9UM73 EXPRESSION TAG SEQRES 1 A 322 GLY ALA MET GLY SER THR ASP TYR ASN PRO ASN TYR CYS SEQRES 2 A 322 PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS GLU SEQRES 3 A 322 VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU GLY SEQRES 4 A 322 HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SER SEQRES 5 A 322 GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA VAL SEQRES 6 A 322 LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU LEU SEQRES 7 A 322 ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE ASN SEQRES 8 A 322 HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU GLN SEQRES 9 A 322 SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA GLY SEQRES 10 A 322 GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO ARG SEQRES 11 A 322 PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU LEU SEQRES 12 A 322 HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR LEU SEQRES 13 A 322 GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA ARG SEQRES 14 A 322 ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL ALA SEQRES 15 A 322 LYS ILE GLY ASP PHE GLY MET ALA ARG ASP ILE TYR ARG SEQRES 16 A 322 ALA SER TYR TYR ARG LYS GLY GLY CYS ALA MET LEU PRO SEQRES 17 A 322 VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY ILE SEQRES 18 A 322 PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL LEU SEQRES 19 A 322 LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR PRO SEQRES 20 A 322 SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SER SEQRES 21 A 322 GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY PRO SEQRES 22 A 322 VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN PRO SEQRES 23 A 322 GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG ILE SEQRES 24 A 322 GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR ALA SEQRES 25 A 322 LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU HET J4M A1500 26 HETNAM J4M N-[(1S)-1-(2,4-DIFLUOROPHENYL)ETHYL]-3-(5-METHYL-1H- HETNAM 2 J4M PYRAZOL-3-YL)IMIDAZO[1,2-B]PYRIDAZIN-6-AMINE FORMUL 2 J4M C18 H16 F2 N6 FORMUL 3 HOH *14(H2 O) HELIX 1 AA1 SER A 1106 LEU A 1108 5 3 HELIX 2 AA2 SER A 1157 PHE A 1174 1 18 HELIX 3 AA3 LEU A 1204 THR A 1211 1 8 HELIX 4 AA4 ALA A 1222 ASN A 1243 1 22 HELIX 5 AA5 ALA A 1251 ARG A 1253 5 3 HELIX 6 AA6 PRO A 1292 MET A 1296 5 5 HELIX 7 AA7 PRO A 1297 GLY A 1304 1 8 HELIX 8 AA8 THR A 1307 SER A 1324 1 18 HELIX 9 AA9 SER A 1334 SER A 1344 1 11 HELIX 10 AB1 PRO A 1355 TRP A 1366 1 12 HELIX 11 AB2 GLN A 1369 ARG A 1373 5 5 HELIX 12 AB3 ASN A 1375 GLN A 1388 1 14 HELIX 13 AB4 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA1 2 ASN A1095 PHE A1098 0 SHEET 2 AA1 2 LYS A1101 SER A1104 -1 O SER A1103 N TYR A1096 SHEET 1 AA2 5 ILE A1116 GLY A1123 0 SHEET 2 AA2 5 VAL A1130 VAL A1135 -1 O VAL A1130 N LEU A1122 SHEET 3 AA2 5 LEU A1145 THR A1151 -1 O VAL A1147 N GLY A1133 SHEET 4 AA2 5 PHE A1193 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 AA2 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 AA3 3 GLY A1202 ASP A1203 0 SHEET 2 AA3 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 AA3 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 0.18 SITE 1 AC1 11 LEU A1122 VAL A1130 ALA A1148 GLU A1197 SITE 2 AC1 11 LEU A1198 MET A1199 GLY A1202 ARG A1253 SITE 3 AC1 11 ASN A1254 LEU A1256 GLY A1269 CRYST1 51.571 57.409 103.410 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019391 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017419 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009670 0.00000